Form 4: Quest Diagnostics Director Acquires and Disposes of Shares in Recent Transaction
SEC Form 4 Filing
A Form 4 filing reveals that Quest Diagnostics Director Luis Diaz acquired and disposed of shares of common stock and was awarded restricted stock units.
Summary
- On May 15, 2025, Luis Diaz, a director at Quest Diagnostics Inc., engaged in transactions involving the company's common stock.
- Diaz acquired 1,203 shares of common stock.
- Diaz also disposed of 4,054 shares of common stock.
- Following these transactions, Diaz directly owns 4,054 shares of Quest Diagnostics Inc.
- Diaz was also awarded restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, allowing investors to monitor the actions of company directors and officers.
Stakeholder Impact
- Shareholders may be interested in the trading activity of company insiders as it can provide insights into management's perspective on the company's value and prospects.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Date of stock acquisition and disposal by Luis Diaz. |
| 05/19/2025 | Date of signature by Attorney in Fact for Luis A. Diaz, Jr., M.D. |
Keywords
Form 4, Quest Diagnostics, Director, Luis Diaz, Stock Transaction, Beneficial Ownership, Restricted Stock Units, DGX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.